Tetrahydroharmol information

Tetrahydroharmol
Clinical data
Other names	1,2-Dihydroharmaline
Identifiers
	IUPAC name 1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-7-ol;
CAS Number	17952-75-9;
PubChem CID	368982;
ChemSpider	327573;
UNII	DHR7GV467K;
ChEMBL	ChEMBL14122;
Chemical and physical data
Formula	C12H14N2O
Molar mass	202.257 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)O;
	InChI InChI=1S/C12H14N2O/c1-7-12-10(4-5-13-7)9-3-2-8(15)6-11(9)14-12/h2-3,6-7,13-15H,4-5H2,1H3; Key:AZTMWIPCEFFOJD-UHFFFAOYSA-N;

Tetrahydroharmol is a bioactive beta-carboline harmala alkaloid.^[1] It acts as a reversible inhibitor of monoamine oxidase A.^[2]

^ Riba J, McIlhenny EH, Valle M, Bouso JC, Barker SA (2012). "Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca". Drug Testing and Analysis. 4 (7–8): 610–616. doi:10.1002/dta.1344. PMID 22514127.
^ Buckholtz NS, Boggan WO (November 1977). "Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity". Biochemical Pharmacology. 26 (21). Elsevier BV: 1991–1996. doi:10.1016/0006-2952(77)90007-7. PMID 921812.

and 4 Related for: Tetrahydroharmol information